APA (7th ed.) Citation

3rd, C. H., JL, C., C, V. L., A, F., M, Y., DE, D., . . . PR, G. (2019). Incorporation of in vitro metabolism data and physiologically based pharmacokinetic modeling in a risk assessment for chloroprene. Inhalation toxicology, 31(13-14), 468. https://doi.org/10.1080/08958378.2020.1715513

Chicago Style (17th ed.) Citation

3rd, Clewell HJ, Campbell JL, Van Landingham C, Franzen A, Yoon M, Dodd DE, Andersen ME, and Gentry PR. "Incorporation of In vitro Metabolism Data and Physiologically Based Pharmacokinetic Modeling in a Risk Assessment for Chloroprene." Inhalation Toxicology 31, no. 13-14 (2019): 468. https://doi.org/10.1080/08958378.2020.1715513.

MLA (9th ed.) Citation

3rd, Clewell HJ, et al. "Incorporation of In vitro Metabolism Data and Physiologically Based Pharmacokinetic Modeling in a Risk Assessment for Chloroprene." Inhalation Toxicology, vol. 31, no. 13-14, 2019, p. 468, https://doi.org/10.1080/08958378.2020.1715513.